biotech

Read more
  • November 19, 2021
  • 0
Primer Sazze Partners, a San Jose-based venture capital firm, announced today it has raised its second fund at $127 million (150 billion won) to invest in startups founded by Korean entrepreneurs in Asia and North America. South Korea-based conglomerate LG Corporation and Hana Financial co-led the second fund, with participation from a number of Korean […]
Read more
  • November 18, 2021
  • 0
The drug development space is continuing to attract more and more investment. On Thursday, another major player, Generate Biomedicines, announced a $370 million Series B round.  Generate Biomedicines is touting a platform-based approach to drug development, but with its own spin: a focus on proteins.  Generate’s thesis is simple: Rather than making connections between targets […]
Read more
  • November 16, 2021
  • 0
Fresh off of a $58 million Series B round, and just one year after graduating from Y combinator, H1, a “LinkedIn for the healthcare industry” has raised even more cash. On Tuesday, the company announced a $100 million Series C round.  The concept behind H1 is simple: it’s an increasingly rich database of medical expertise. […]
Read more
  • November 12, 2021
  • 0
Each year millions of people are diagnosed with cancer. Meanwhile, hundreds of clinical trials testing potential treatments are ongoing. But there’s a gap between the people who need treatment and the people who actually end up in those studies.  Women and ethnic minorities are often underrepresented in cancer trials. For example, one 2018 meta-review of […]
Read more
  • November 4, 2021
  • 0
The field of drug discovery has been supercharged by the capabilities of AI, which several companies have applied in various ways to turn an enormous practical problem into a tractable information problem. The latest to do so is Google parent company Alphabet, which has established Isomorphic Labs, under DeepMind head Demis Hassabis, to take its […]